Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, February 11, 2020
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
[ Tue, Feb 11th 2020
] - WOPRAI
Mon, February 10, 2020
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
[ Mon, Feb 10th 2020
] - WOPRAI
Mani Foroohar Maintained (ABEO) at Buy and Held Target at $150 on, Feb 10th, 2020
Mani Foroohar of SVB Leerink, Maintained "Abeona Therapeutics Inc." (ABEO) at Buy and Held Target at $150 on, Feb 10th, 2020.
Mani has made no other calls on ABEO in the last 4 months.
There is 1 other peer that has a rating on ABEO. Out of the 1 peers that are also analyzing ABEO, 0 agree with Mani's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mani
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $275 on, Monday, December 30th, 2019
Similar Stocks and Investing Articles
[ Mon, Feb 03rd 2020
] - WOPRAI
[ Fri, Jan 31st 2020
] - WOPRAI
[ Tue, Jan 28th 2020
] - WOPRAI
[ Wed, Jan 08th 2020
] - WOPRAI
[ Mon, Dec 30th 2019
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Thu, Feb 07th 2019
] - WOPRAI